Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2020

IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction)

Presenter: Rodrigo Estévez-Loureiro

October 17, 2020

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

Presenter: Gregg Stone

October 14, 2020

Presentation TCT 2020

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Presenter: Byeong-Keuk Kim

October 14, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation

Incidence, Presentation, and Causes of 30-Day Readmission After Hospitalization With SCAD

April 20, 2020

Presentation

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

April 15, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Presentation ACC 2020

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

Presenter: Zakaria Almuwaqqat

March 30, 2020

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation

Association of Sex With Outcomes in Patients Undergoing PCI

January 31, 2020

Presentation

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

January 28, 2020

Presentation

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

January 15, 2020

Presentation CACI 2019

Después del COMPLETE Trial, ¿cambió nuestra estrategia de revascularización en el IAM?

Presenter: José A. G. Álvarez

November 29, 2019

Advertisement

IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction)

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Incidence, Presentation, and Causes of 30-Day Readmission After Hospitalization With SCAD

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

Optimal LDL levels in patients with ACS undergoing PCI

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Association of Sex With Outcomes in Patients Undergoing PCI

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

Después del COMPLETE Trial, ¿cambió nuestra estrategia de revascularización en el IAM?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content